 TLE1/2/3/4 Polyclonal Antibody |
|||
| ABP57471-02ml | Abbkine | 0.2ml | EUR 414 |
|
|||
|
Description: A polyclonal antibody for detection of TLE1/2/3/4 from Human, Mouse, Rat. This TLE1/2/3/4 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from TLE1/2/3/4 at AA range: 721-770 |
|||
TLE1/2/3/4 Polyclonal Antibody |
|||
| ES8464-100ul | ELK Biotech | 100ul | EUR 279 |
|
Description: A Rabbit Polyclonal antibody against TLE1/2/3/4 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
|||
TLE1/2/3/4 Polyclonal Antibody |
|||
| ES8464-50ul | ELK Biotech | 50ul | EUR 207 |
|
Description: A Rabbit Polyclonal antibody against TLE1/2/3/4 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
|||
 TLE1/2/3/4 Polyclonal Conjugated Antibody |
|||
| C46729 | SAB | 100ul | EUR 397 |
 Anti-TLE1/2/3/4 Antibody |
|||
| A02460 | BosterBio | 100ul | EUR 397 |
|
Description: Rabbit Polyclonal Antibody for TLE1/2/3/4 Antibody (TLE1) detection.tested for IHC, WB in Human, Mouse, Rat. |
|||
 Anti-TLE1/2/3/4 antibody |
|||
| STJ98577 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to TLE1/2/3/4. |
|||
 TLE1 Rabbit pAb |
|||
| A13360-100ul | Abclonal | 100 ul | EUR 308 |
TLE1 Rabbit pAb |
|||
| A13360-200ul | Abclonal | 200 ul | EUR 459 |
TLE1 Rabbit pAb |
|||
| A13360-20ul | Abclonal | 20 ul | EUR 183 |
TLE1 Rabbit pAb |
|||
| A13360-50ul | Abclonal | 50 ul | EUR 223 |
 TLE1 Rabbit mAb |
|||
| A3528-100ul | Abclonal | 100 ul | EUR 410 |
TLE1 Rabbit mAb |
|||
| A3528-200ul | Abclonal | 200 ul | EUR 571 |
TLE1 Rabbit mAb |
|||
| A3528-20ul | Abclonal | 20 ul | EUR 221 |
TLE1 Rabbit mAb |
|||
| A3528-50ul | Abclonal | 50 ul | EUR 287 |
TLE1 Rabbit pAb |
|||
| A5501-100ul | Abclonal | 100 ul | EUR 308 |
TLE1 Rabbit pAb |
|||
| A5501-200ul | Abclonal | 200 ul | EUR 459 |
TLE1 Rabbit pAb |
|||
| A5501-20ul | Abclonal | 20 ul | EUR 183 |
TLE1 Rabbit pAb |
|||
| A5501-50ul | Abclonal | 50 ul | EUR 223 |
 Rabbit Monoclonal Antibody, Clone#RM355) Anti-Cytokeratin 4 (CK-4) Rabbit Monoclonal Antibody, Clone#RM355 |
|||
| M07410-2 | BosterBio | 100uL | EUR 385 |
|
Description: Anti-Cytokeratin 4 (CK-4) Rabbit Monoclonal Antibody, Clone#RM355 tested in WB, IHC, reactive to Human |
|||
) Polyclonal TLE1 Antibody (N-term) |
|||
| AMM08213G | Leading Biology | 0.1ml | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TLE1 (N-term). This antibody is tested and proven to work in the following applications: |
|||
Polyclonal TLE1 Antibody (N-term) |
|||
| AMM08214G | Leading Biology | 0.1ml | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TLE1 (N-term). This antibody is tested and proven to work in the following applications: |
|||
 Rabbit Polyclonal Antibody to Human Topoisomerase IIb |
|||
| TG2010-3 | TopoGen | 250 units | EUR 414 |
 TLE1 antibody |
|||
| 70R-20844 | Fitzgerald | 50 ul | EUR 435 |
|
Description: Rabbit polyclonal TLE1 antibody |
|||
 TLE1 Antibody |
|||
| 32891-100ul | SAB | 100ul | EUR 252 |
TLE1 Antibody |
|||
| 1-CSB-PA717264ESR1HU | Cusabio |
|
|
|
|||
|
Description: A polyclonal antibody against TLE1. Recognizes TLE1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA |
|||
TLE1 Antibody |
|||
| DF7380 | Affbiotech | 200ul | EUR 304 |
|
Description: TLE1 Antibody detects endogenous levels of total TLE1. |
|||
TLE1 antibody |
|||
| 70R-7915 | Fitzgerald | 50 ug | EUR 467 |
|
Description: Affinity purified rabbit polyclonal TLE1 antibody |
|||
TLE1 Antibody |
|||
| 1-CSB-PA023585GA01HU | Cusabio |
|
|
|
|||
|
Description: A polyclonal antibody against TLE1. Recognizes TLE1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA |
|||
TLE1 Antibody |
|||
| ABD7380 | Lifescience Market | 100 ug | EUR 438 |
 Rabbit Polyclonal Antibody to Human Topoisomerase IIIb |
|||
| TG2010-4 | TopoGen | 250 units | EUR 380 |
 Anti-14-3-3 alpha + beta Rabbit Monoclonal Antibody |
|||
| M02431-3 | BosterBio | 100ug/vial | EUR 397 |
|
Description: Rabbit Monoclonal 14-3-3 alpha + beta Antibody. Validated in Flow Cytometry, IP, IF, IHC, ICC, WB and tested in Human, Mouse, Rat. |
|||
 Anti-active Caspase-3 Rabbit Monoclonal Antibody |
|||
| M00334-3 | BosterBio | 100ug/vial | EUR 397 |
|
Description: Anti-active Caspase-3 Rabbit Monoclonal Antibody tested for IF, IHC, ICC, WB in Human |
|||
) Rabbit Polyclonal Antibody to Human Topoisomerase I (Rabbit Serum) |
|||
| TG2012-2 | TopoGen | 250 ul | EUR 380 |
 Anti-14-3-3 Rabbit Monoclonal Antibody |
|||
| M02431-2 | BosterBio | 100ug/vial | EUR 397 |
|
Description: Rabbit Monoclonal 14-3-3 Antibody. Validated in WB and tested in Human, Mouse, Rat. |
|||
 Anti-Bcl-2 Rabbit Monoclonal Antibody |
|||
| M00040-2 | BosterBio | 100ug/vial | EUR 397 |
|
Description: Rabbit Monoclonal Bcl-2 Antibody. Validated in IF, WB and tested in Human, Mouse. |
|||
 Polyclonal TLE1 antibody - N-terminal region |
|||
| AMM08215G | Leading Biology | 0.05mg | EUR 528 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TLE1 - N-terminal region. This antibody is tested and proven to work in the following applications: |
|||
 MARK1/2/3/4 Polyclonal Antibody |
|||
| 41121-100ul | SAB | 100ul | EUR 252 |
MARK1/2/3/4 Polyclonal Antibody |
|||
| 41121-50ul | SAB | 50ul | EUR 187 |
 EphB1/2/3/4 Polyclonal Antibody |
|||
| ABP54135-003ml | Abbkine | 0.03ml | EUR 158 |
|
|||
|
Description: A polyclonal antibody for detection of EphB1/2/3/4 from Human, Mouse. This EphB1/2/3/4 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human EphB1/2/3/4 around the non-phosphorylation site of Y600/602/614/596 |
|||
EphB1/2/3/4 Polyclonal Antibody |
|||
| ABP54135-01ml | Abbkine | 0.1ml | EUR 289 |
|
|||
|
Description: A polyclonal antibody for detection of EphB1/2/3/4 from Human, Mouse. This EphB1/2/3/4 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human EphB1/2/3/4 around the non-phosphorylation site of Y600/602/614/596 |
|||
EphB1/2/3/4 Polyclonal Antibody |
|||
| ABP54135-02ml | Abbkine | 0.2ml | EUR 414 |
|
|||
|
Description: A polyclonal antibody for detection of EphB1/2/3/4 from Human, Mouse. This EphB1/2/3/4 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human EphB1/2/3/4 around the non-phosphorylation site of Y600/602/614/596 |
|||
MARK1/2/3/4 Polyclonal Antibody |
|||
| ABP51746-003ml | Abbkine | 0.03ml | EUR 158 |
|
|||
|
Description: A polyclonal antibody for detection of MARK1/2/3/4 from Human, Mouse, Rat. This MARK1/2/3/4 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human MARK1/2/3/4 at AA range: 90-170 |
|||
MARK1/2/3/4 Polyclonal Antibody |
|||
| ABP51746-01ml | Abbkine | 0.1ml | EUR 289 |
|
|||
|
Description: A polyclonal antibody for detection of MARK1/2/3/4 from Human, Mouse, Rat. This MARK1/2/3/4 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human MARK1/2/3/4 at AA range: 90-170 |
|||
MARK1/2/3/4 Polyclonal Antibody |
|||
| ABP51746-02ml | Abbkine | 0.2ml | EUR 414 |
|
|||
|
Description: A polyclonal antibody for detection of MARK1/2/3/4 from Human, Mouse, Rat. This MARK1/2/3/4 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human MARK1/2/3/4 at AA range: 90-170 |
|||
MARK1/2/3/4 Polyclonal Antibody |
|||
| ABP51747-003ml | Abbkine | 0.03ml | EUR 158 |
|
|||
|
Description: A polyclonal antibody for detection of MARK1/2/3/4 from Human, Mouse, Rat, Monkey. This MARK1/2/3/4 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human MARK1/2/3/4 around the non-phosphorylation site of T215 |
|||
MARK1/2/3/4 Polyclonal Antibody |
|||
| ABP51747-01ml | Abbkine | 0.1ml | EUR 289 |
|
|||
|
Description: A polyclonal antibody for detection of MARK1/2/3/4 from Human, Mouse, Rat, Monkey. This MARK1/2/3/4 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human MARK1/2/3/4 around the non-phosphorylation site of T215 |
|||
MARK1/2/3/4 Polyclonal Antibody |
|||
| ABP51747-02ml | Abbkine | 0.2ml | EUR 414 |
|
|||
|
Description: A polyclonal antibody for detection of MARK1/2/3/4 from Human, Mouse, Rat, Monkey. This MARK1/2/3/4 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human MARK1/2/3/4 around the non-phosphorylation site of T215 |
|||
MARK1/2/3/4 Polyclonal Antibody |
|||
| ES2745-100ul | ELK Biotech | 100ul | EUR 279 |
|
Description: A Rabbit Polyclonal antibody against MARK1/2/3/4 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA |
|||
MARK1/2/3/4 Polyclonal Antibody |
|||
| ES2745-50ul | ELK Biotech | 50ul | EUR 207 |
|
Description: A Rabbit Polyclonal antibody against MARK1/2/3/4 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA |
|||
MARK1/2/3/4 Polyclonal Antibody |
|||
| ES2746-100ul | ELK Biotech | 100ul | EUR 279 |
|
Description: A Rabbit Polyclonal antibody against MARK1/2/3/4 from Human/Mouse/Rat/Monkey. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA |
|||
MARK1/2/3/4 Polyclonal Antibody |
|||
| ES2746-50ul | ELK Biotech | 50ul | EUR 207 |
|
Description: A Rabbit Polyclonal antibody against MARK1/2/3/4 from Human/Mouse/Rat/Monkey. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA |
|||
EphB1/2/3/4 Polyclonal Antibody |
|||
| ES5134-100ul | ELK Biotech | 100ul | EUR 279 |
|
Description: A Rabbit Polyclonal antibody against EphB1/2/3/4 from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
|||
EphB1/2/3/4 Polyclonal Antibody |
|||
| ES5134-50ul | ELK Biotech | 50ul | EUR 207 |
|
Description: A Rabbit Polyclonal antibody against EphB1/2/3/4 from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
|||
 (TLE1/2085) Antibody) TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNCR2085-250 | Biotium | 250uL | EUR 394 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), RPE conjugate, Concentration: 0.1mg/mL |
|||
 (TLE1/2946R) Antibody) TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNCR2946-250 | Biotium | 250uL | EUR 394 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), RPE conjugate, Concentration: 0.1mg/mL |
|||
 (TLE1/2051) Antibody) TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNUB2051-100 | Biotium | 100uL | EUR 264 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), Concentration: 0.2mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNUB2051-50 | Biotium | 50uL | EUR 405 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), 1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNUB2051-500 | Biotium | 500uL | EUR 513 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), Concentration: 0.2mg/mL |
|||
 (TLE1/2062) Antibody) TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNUB2062-100 | Biotium | 100uL | EUR 264 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), Concentration: 0.2mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNUB2062-50 | Biotium | 50uL | EUR 405 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), 1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNUB2062-500 | Biotium | 500uL | EUR 513 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), Concentration: 0.2mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNUB2085-100 | Biotium | 100uL | EUR 264 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), Concentration: 0.2mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNUB2085-50 | Biotium | 50uL | EUR 405 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), 1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNUB2085-500 | Biotium | 500uL | EUR 513 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), Concentration: 0.2mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNUB2946-100 | Biotium | 100uL | EUR 264 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), Concentration: 0.2mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNUB2946-50 | Biotium | 50uL | EUR 405 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), 1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNUB2946-500 | Biotium | 500uL | EUR 513 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), Concentration: 0.2mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC552051-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF555 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC552051-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF555 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC552062-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF555 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC552062-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF555 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC552085-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF555 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC552085-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF555 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNC552946-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF555 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNC552946-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF555 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC612051-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF660R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC612051-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF660R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC612062-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF660R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC612062-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF660R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC612085-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF660R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC612085-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF660R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC432062-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF543 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC432062-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF543 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC432085-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF543 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC432085-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF543 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNC432946-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF543 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNC432946-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF543 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC472051-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF647 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC472051-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF647 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC472062-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF647 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC472062-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF647 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC472085-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF647 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC472085-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF647 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNC472946-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF647 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNC472946-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF647 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC042051-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF405S conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC042051-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF405S conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC042062-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF405S conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC042062-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF405S conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC042085-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF405S conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC042085-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF405S conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNC042946-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF405S conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNC042946-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF405S conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC052051-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF405M conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC052051-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF405M conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC052062-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF405M conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC052062-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF405M conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC052085-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF405M conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC052085-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF405M conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNC052946-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF405M conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNC052946-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF405M conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC402051-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF640R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC402051-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF640R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC402062-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF640R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC402062-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF640R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC402085-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF640R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC402085-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF640R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNC402946-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF640R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNC402946-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF640R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC432051-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF543 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC432051-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF543 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC702051-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF770 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC702051-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF770 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC702062-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF770 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC702062-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF770 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC702085-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF770 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC702085-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF770 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNC702946-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF770 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNC702946-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF770 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC802051-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF680 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC802051-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF680 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC802062-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF680 conjugate, Concentration: 0.1mg/mL |
|||